tradingkey.logo

BRIEF-Dyne Therapeutics Receives FDA Fast Track Designation For Dyne-101

ReutersJan 21, 2025 12:43 PM

- Dyne Therapeutics Inc DYN.O:

  • DYNE THERAPEUTICS RECEIVES FDA FAST TRACK DESIGNATION FOR DYNE-101 FOR THE TREATMENT OF MYOTONIC DYSTROPHY TYPE 1

  • DYNE THERAPEUTICS INC - TO SUBMIT FOR U.S. ACCELERATED APPROVAL IN H1 2026

Source text: ID:nGNX9m9Xf2

Further company coverage: DYN.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI